ESSENTIAL THROMBOCYTHEMIA (ET)
What is Essential Thrombocythemia (ET)?
Essential Thrombocythemia (ET) is a chronic myeloproliferative neoplasm (MPN) characterized by an increased number of platelets in the blood. Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding. Less common consequences in the later stages of ET include a transformation to myelofibrosis (marrow scarring) or acute leukemia.
Click here if you would like to watch an overview video of the diagnosis, presenting symptoms, disease course, and treatment options of essential thrombocythemia for patients, their caregivers, and their loved ones created by Dr. Ruben A. Mesa and Dr. Robyn M. Scherber of UT Health San Antonio, MD Anderson Cancer Center.
Nutrition Recommendations for MPN Patients
By: Dr. Robyn Scherber, MD; Dr. Ruben Mesa, MD; Ryan Eckert, MS, Mays Cancer Center at UT Health San Antonio MD Anderson MPN Quality of Life Study Group; www.mpnqol
Subscribe to updates to learn more about available PMF treatments.
Learn about LORRAINE’s MF diagnosis and what she’s doing to make a difference in MPN research